Press Releases
October 31, 2018
23andMe Granted the First and Only FDA Authorization For Direct-to-Consumer Pharmacogenetic Reports
The decision allows 23andMe to report directly to customers, without a prescription, the influence their genetics have on how well they metabolize certain medications (Updated Nov. 1, 2018 2:30 PM…
July 25, 2018
GSK and 23andMe sign agreement to leverage genetic insights for the development of novel medicines
Multi-year collaboration expected to identify novel drug targets, tackle new subsets of disease and enable rapid progression of clinical programsLONDON, UK and MOUNTAIN VIEW, CA — July 25, 2018, GSK and…
March 06, 2018
23andMe Granted First FDA Authorization for Direct-to-Consumer Genetic Test on Cancer Risk
Authorization allows 23andMe to report on BRCA1- and BRCA2-related genetic risk for breast, ovarian and prostate cancerMountain View, California – March 6, 2018 – 23andMe, Inc., the leading personal genetics…